Your session is about to expire
← Back to Search
Radiotherapy for Rectal Cancer
Study Summary
This trial is testing a new way to give radiation and chemotherapy for rectal cancer. The goal is to see if it will kill the cancer cells and help prevent the cancer from coming back.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My cancer has spread to the fatty tissue near my rectum.I am not fit for the study treatment or surgery.I have been diagnosed with Gilbert's syndrome.I am medically cleared for cancer surgery.I am fully active or can carry out light work.My cancer is early stage and hasn't spread to my veins.My heart or lung condition is not well-controlled.I am not pregnant, breastfeeding, or if pre-menopausal, I am using effective birth control.I have had radiation treatment to my pelvic area before.My cancer has spread to other parts of my body.My cancer has spread to the muscle layer of my organ.I am currently taking warfarin, phenytoin, or sorivudine.My MRI shows my cancer has spread to or beyond the mesorectum.I have a known deficiency in the enzyme dihydropyrimidine dehydrogenase.My cancer has spread to the blood vessels outside the organ.My kidneys are working well.I have severe bowel issues without a stoma.I have enlarged lymph nodes outside the rectal area.I do not have a stomach or bowel problem that affects medication absorption.I have not had any cancer in the past 5 years, except for skin or cervical cancer that was successfully treated.I have cancer in one or more lymph nodes near my rectum.I am 18 years old or older.My scans show no signs of cancer spread beyond the original site.
- Group 1: Radical External Beam RT for Colorectal Ca
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there vacancies in this clinical experiment for participants?
"According to information on clinicaltrials.gov, participants are presently being recruited for this medical trial which was initially published on March 1st 2015 and revised most recently on September 8th 2022."
Do I meet the prerequisites to be a part of this experiment?
"As part of this trial, 48 participants aged 18 to 90 years old with colorectal carcinoma must satisfy the essential criteria: involvement or breach of mesorectum (T3-T4), presence of extra-mural vascular invasion, tumor deposits in the mesorectum and an ECOG performance status score 0 or 1."
How many participants are contributing to this clinical experiment?
"Affirmative, the information on clinicaltrials.gov states that this research project is presently engaging potential participants. The trial was initially listed on March 1st 2015 and underwent its most recent revision on September 8th 2022. This experiment seeks 48 individuals from 2 different locations for participation."
Are those over 65 years of age excluded from the scope of this experiment?
"This clinical trial is recruiting those aged 18 and older who have not yet reached their ninetieth year."
Share this study with friends
Copy Link
Messenger